What does APOTHEEK GRIMBERGEN do?

APOTHEEK GRIMBERGEN is a pharmacy in Grimbergen. Private Limited, started on 28 March 2019, 1 establishment.

What is the address of APOTHEEK GRIMBERGEN?

The registered office of APOTHEEK GRIMBERGEN is located at Vilvoordsesteenweg 303, 1850 Grimbergen.

Is APOTHEEK GRIMBERGEN still active?

Yes. According to the CBE (30 September 2026) APOTHEEK GRIMBERGEN is active, legal situation “Normale toestand”, started on 28 March 2019.

Is APOTHEEK GRIMBERGEN registered on Peppol?

Yes, APOTHEEK GRIMBERGEN is registered on the Peppol network with ID 0208:0723730856.

What is the enterprise number of APOTHEEK GRIMBERGEN?

The enterprise number of APOTHEEK GRIMBERGEN is BE0723730856.

When was APOTHEEK GRIMBERGEN founded?

APOTHEEK GRIMBERGEN was founded on 28 March 2019.

Who are the directors of APOTHEEK GRIMBERGEN?

According to the 2025 annual accounts, the directors of APOTHEEK GRIMBERGEN are: FARMAKS CONSULTANCY BV.

Is APOTHEEK GRIMBERGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 March 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK GRIMBERGEN make in 2025?

APOTHEEK GRIMBERGEN posted a profit after taxes of € 2,320 in financial year 2025.

What is the revenue of APOTHEEK GRIMBERGEN?

As a small company, APOTHEEK GRIMBERGEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 159,597.

APOTHEEK GRIMBERGEN (Private Limited) - Grimbergen

Dossier APOTHEEK GRIMBERGEN, printed on 30 September 2026 from databakkes.be/en/0723730856/apotheek-grimbergen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK GRIMBERGEN from Grimbergen, company number BE0723730856, closed financial year 2025 with a result of € 2,320 after tax. For that financial year APOTHEEK GRIMBERGEN recorded a gross margin of € 159,597 and equity of € 152,784. Compared with financial year 2024, the result moved from € 43,019 to € 2,320. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.

What it is worth Growing

€ 152,784

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 2,320

▼ 95% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,401

▼ 62% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 146,584.

People and assets in 2025

Wage cost

€ 79,674

▲ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 28,562

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 644,469

▼ 1% vs 2024

€ 63,001 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 151,526

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 7,706

▼ 12% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 55,937 Gross margin 2022: € 55,937 First fiscal year in the series	€ 263,806 Gross margin 2023: € 263,806 ▲ € 207,869 vs 2022 (€ 55,937) Favourable step	€ 212,677 Gross margin 2024: € 212,677 ▼ 19% vs 2023 (€ 263,806) Unfavourable step	€ 159,597 Gross margin 2025: € 159,597 ▼ 25% vs 2024 (€ 212,677) Unfavourable step	▼ 25%
Profit after taxes	€ 33,034 Profit after taxes 2022: € 33,034 First fiscal year in the series	€ 108,254 Profit after taxes 2023: € 108,254 ▲ 228% vs 2022 (€ 33,034) Favourable step	€ 43,019 Profit after taxes 2024: € 43,019 ▼ 60% vs 2023 (€ 108,254) Unfavourable step	€ 2,320 Profit after taxes 2025: € 2,320 ▼ 95% vs 2024 (€ 43,019) Unfavourable step	▼ 95%
Equity	€ -809 Equity 2022: € -809 First fiscal year in the series	€ 107,445 Equity 2023: € 107,445 ▲ € 108,254 vs 2022 (€ -809) Favourable step	€ 150,464 Equity 2024: € 150,464 ▲ 40% vs 2023 (€ 107,445) Favourable step	€ 152,784 Equity 2025: € 152,784 ▲ 2% vs 2024 (€ 150,464) Favourable step	▲ 2%
Total debts	€ 887,146 Total debts 2022: € 887,146 First fiscal year in the series	€ 1,067,338 Total debts 2023: € 1,067,338 ▲ 20% vs 2022 (€ 887,146) Unfavourable step	€ 937,049 Total debts 2024: € 937,049 ▼ 12% vs 2023 (€ 1,067,338) Favourable step	€ 999,089 Total debts 2025: € 999,089 ▲ 7% vs 2024 (€ 937,049) Unfavourable step	▲ 7%
Cash	€ 27,468 Cash 2022: € 27,468 First fiscal year in the series	€ 27,253 Cash 2023: € 27,253 ▼ 1% vs 2022 (€ 27,468) Unfavourable step	€ 27,701 Cash 2024: € 27,701 ▲ 2% vs 2023 (€ 27,253) Favourable step	€ 10,401 Cash 2025: € 10,401 ▼ 62% vs 2024 (€ 27,701) Unfavourable step	▼ 62%
Retained profit	€ -7,009 Retained profit 2022: € -7,009 First fiscal year in the series	€ 101,245 Retained profit 2023: € 101,245 ▲ € 108,254 vs 2022 (€ -7,009) Favourable step	€ 144,264 Retained profit 2024: € 144,264 ▲ 42% vs 2023 (€ 101,245) Favourable step	€ 146,584 Retained profit 2025: € 146,584 ▲ 2% vs 2024 (€ 144,264) Favourable step	▲ 2%
Bank debt	€ 794,888 Bank debt 2022: € 794,888 First fiscal year in the series	€ 741,855 Bank debt 2023: € 741,855 ▼ 7% vs 2022 (€ 794,888) Favourable step	€ 653,826 Bank debt 2024: € 653,826 ▼ 12% vs 2023 (€ 741,855) Favourable step	€ 644,469 Bank debt 2025: € 644,469 ▼ 1% vs 2024 (€ 653,826) Favourable step	▼ 1%
Balance sheet total	€ 886,337 Balance sheet total 2022: € 886,337 First fiscal year in the series	€ 1,174,784 Balance sheet total 2023: € 1,174,784 ▲ 33% vs 2022 (€ 886,337) Unchanged	€ 1,087,513 Balance sheet total 2024: € 1,087,513 ▼ 7% vs 2023 (€ 1,174,784) Unchanged	€ 1,151,873 Balance sheet total 2025: € 1,151,873 ▲ 6% vs 2024 (€ 1,087,513) Unchanged	▲ 6%

Key figures of APOTHEEK GRIMBERGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to APOTHEEK GRIMBERGEN?

What happened at APOTHEEK GRIMBERGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 21, 2026 New annual accounts for financial year 2025: profit of € 2,320 (▼ 95% vs 2024). Source: NBB ↗
Apr 1, 2019 New establishment in Grimbergen. KBO
Mar 28, 2019 Start of the company according to the CBE. KBO

In short

From € 33,034 profit in 2022 to € 2,320 profit in 2025.

Paid € 383 in corporate taxes since 2022.

Best year ever: 2023, with € 108,254 profit.

Original PDFs at the National Bank ↗

A new publication or filing at APOTHEEK GRIMBERGEN? We notify you, reason included.

Follow APOTHEEK GRIMBERGEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

FARMAKS CONSULTANCY BV

APOTHEEK GRIMBERGEN

Behind APOTHEEK GRIMBERGEN is FARMAKS CONSULTANCY BV.

See the full network in the app

Directors

According to the 2025 annual accounts

FARMAKS CONSULTANCY BV

Director · represented by KAREN POTOMS

Establishments

Establishment units

Physical locations of this company

Registered office

Vilvoordsesteenweg 303

1850 Grimbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0723.730.856

VAT number

BE 0723.730.856

Registered office

Vilvoordsesteenweg 303, 1850 Grimbergen

Names & denominations

APOTHEEK GRIMBERGEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 March 2019

Peppol

Active · Active since 12 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vermogensbeheer

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK GRIMBERGEN

Warning lights

Financials

What happened to APOTHEEK GRIMBERGEN?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions